Healthcare
ID: MRFR/HC/18016-HCR
100 Pages
Garvit Vyas
10/2025
ID: MRFR/HC/18015-HCR
100 Pages
Garvit Vyas
10/2025
ID: MRFR/HC/18013-HCR
100 Pages
Garvit Vyas
10/2025
ID: MRFR/HC/18012-HCR
100 Pages
Garvit Vyas
10/2025
ID: MRFR/HC/18009-HCR
100 Pages
Garvit Vyas
10/2025
US Uveitis Treatment Market Research Report By Treatment Type (Corticosteroids, Immunosuppressants, Biologic Therapies, Antiviral Medications), By Route of Administration (Topical, Systemic, Injectable, Intravitreal), By Indication (Anterior Uveitis, Intermediate Uveitis, Posterior Uveitis, Panuveitis) and By Distribution Channel (Hospitals, Clinics, Online Pharmacies, Retail Pharmacies) - Forecast to 2035
ID: MRFR/HC/18007-HCR
100 Pages
Garvit Vyas
10/2025
US Urinary Drainage Bags Market Research Report By Product Type (Leg Bags, Bedside Bags, Irrigation Bags, Single Use Bags), By Material (Vinyl, Polyethylene, Rubber, Silicone), By End User (Hospitals, Long-term Care Facilities, Homecare) and By Application (Urological Surgery, Chronic Kidney Disease, Post-surgical Management) - Forecast to 2035
ID: MRFR/HC/18000-HCR
100 Pages
Garvit Vyas
10/2025
ID: MRFR/HC/17999-HCR
100 Pages
Garvit Vyas
10/2025
US Thalassemia Treatment Market Research Report By Treatment Type (Blood Transfusion, Chelation Therapy, Bone Marrow Transplantation, Gene Therapy, Supportive Care), By Route of Administration (Intravenous, Oral, Subcutaneous), By Patient Age Group (Pediatric, Adult, Geriatric) and By Therapeutic Area (Hematology, Oncology, Immunology) - Forecast to 2035
ID: MRFR/HC/17995-HCR
100 Pages
Garvit Vyas
10/2025
US Systemic Lupus Erythematosus Treatment Market Research Report By Treatment Type (Immunosuppressants, Antimalarials, Nonsteroidal Anti-Inflammatory Drugs, Corticosteroids), By Route of Administration (Oral, Intravenous, Subcutaneous), By End User (Hospitals, Specialized Clinics, Homecare Settings) and By Patient Demographics (Pediatric, Adult, Geriatric) - Forecast to 2035
ID: MRFR/HC/17991-HCR
100 Pages
Garvit Vyas
10/2025
US Sturge-Weber Syndrome Market Research Report By Type (Type I, Type II, Type III), By End User (Clinics and Hospitals, Diagnostic Centres, Others), By Diagnosis (Electroencephalogram (EEG), Skull Radiography, Computer Tomography (CT) Scan, Magnetic Resonance Imaging (MRI)), By Treatment (Surgical Procedure, Laser Therapy, Medication) and By Medication Type (Antiglaucoma, Carbonic Anhydrase Inhibitors, Beta Antagonist Eye Drops, Latanoprost, Antiepileptic) - Forecast to 2035